Evaluation of HBsAg Seroclearance in Patients with Hepatitis B

OBJECTIVE: Hepatitis B surface antigen (HBsAg) seroclearance/seroconversion is regarded as an indicator of the ultimate immune control of hepatitis B virus (HBV) infections. HBsAg loss is the most important endpoint, as it shows deep suppression of HBV replication and viral protein expression. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Taşkın, Mehmet Can, Uyanikoglu, Ahmet, Cindoglu, Cigdem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028705/
https://www.ncbi.nlm.nih.gov/pubmed/36959985
http://dx.doi.org/10.5005/jp-journals-10018-1352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028705/
https://www.ncbi.nlm.nih.gov/pubmed/36959985
http://dx.doi.org/10.5005/jp-journals-10018-1352

Ejemplares similares